Medicine and Dentistry
Human Immunodeficiency Virus
83%
Antiretroviral Therapy
36%
Cytomegalovirus Infection
23%
Infection
22%
Phlebothrombosis
21%
Cytomegalovirus
21%
Highly Active Antiretroviral Therapy
16%
Human Immunodeficiency Virus Infection
15%
Disease
15%
Venous Thromboembolism
12%
Physical Examination
12%
HIV Type 1
12%
Reverse-Transcriptase Inhibitor
11%
Artery Thrombosis
9%
Nevirapine
8%
Diagnosis
8%
Kaposi Sarcoma
7%
Case-Control Study
7%
Cardiovascular System
7%
Monotherapy
7%
Procoagulant
7%
Abacavir/Lamivudine/Zidovudine
6%
Cohort Analysis
6%
Dengue Fever
6%
Retrospective Cohort Study
6%
Advanced Glycation End-Product
6%
Peginterferon Alpha
6%
Malignant Neoplasm
6%
Mesenteric Vein Thrombosis
6%
Autofluorescence
6%
Nelfinavir
6%
Puerperium
6%
Side Effect
6%
Acute Hepatitis C
6%
Aspergillosis
6%
Immigrant
6%
Heart Graft
6%
Immunocompromised Patient
6%
Systematic Review
6%
HIV/AIDS
6%
Nucleoside
6%
Volvulus
6%
Cancer
6%
Opportunistic Infection
6%
T-Helper Cell
5%
T Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
RNA Directed DNA Polymerase Inhibitor
18%
Vein Thrombosis
18%
Proteinase Inhibitor
14%
Human Immunodeficiency Virus Infection
13%
Abacavir Plus Lamivudine Plus Zidovudine
12%
Cohort Study
12%
Infection
12%
Peginterferon Alpha
12%
Acute Hepatitis C
12%
Monotherapy
12%
Artery Thrombosis
9%
Randomized Controlled Trial
8%
Nevirapine
8%
Human Immunodeficiency Virus 1 Infection
7%
Nonnucleoside Reverse Transcriptase Inhibitor
7%
Efavirenz
7%
Lopinavir Plus Ritonavir
7%
Case-Control Study
7%
Side Effect
7%
Disease
6%
Abacavir Plus Lamivudine
6%
Emtricitabine
6%
Nucleoside
6%
Cytomegalovirus Infection
6%
CYP2B6
6%
Malignant Neoplasm
6%
Nelfinavir
6%
Sorivudine
6%
Randomized Clinical Trial
6%
Pharmacokinetics
6%
Heart Infarction
6%
Venous Thromboembolism
6%
Tenofovir
6%
Aciclovir
6%
Herpes Zoster
6%
Hepatitis C
6%
Opportunistic Infection
6%
Dengue
6%
Rash
5%
Ribavirin
5%
Antivirus Agent
5%
Keyphrases
Combined Antiretroviral Therapy (cART)
15%
Netherlands
12%
HIV Patients
10%
Zidovudine
8%
Lopinavir
7%
Antiretroviral Therapy Regimens
7%
Dual Infection
6%
Enfuvirtide
6%
HIV-1 Envelope
6%
Lamb Waves
6%
Hybrid Capture
6%
Kaposi Sarcoma
6%
Murex
6%
HIV-related Kaposi's Sarcoma
6%
Chirplet Transform
6%
HIV-positive Women
6%
Attenuation Analysis
6%
Venous Thrombosis
6%
Rhodococcus Equi
6%
T-cell Prolymphocytic Leukemia
6%
Emtricitabine
6%
Antiretroviral Naïve
6%
Immune Restoration
6%
Antiretroviral Therapy
6%
Nelfinavir
6%
AIDS Epidemic
6%
T-cell Count
6%
Efavirenz
6%
CD4-positive T Cells
6%
Cell Mortality
6%
AIDS Patients
6%
Renal Aspergillosis
6%
Acute Venous Thrombosis
6%
Review of Reported Cases
6%
Lactoferrin
6%
Infective Immigrants
6%
Treatment Quality
6%
Cardiovascular Events
6%
Pneumocystis Jirovecii
6%
Retrospective Cohort Study
6%
AIDS/HIV
6%
Capture-recapture Analysis
6%
Sorivudine
6%
Treatment Adherence
6%
Cytomegalovirus Antigenemia
6%
National Registration
6%
HIV Infection
6%
Life Satisfaction
6%
Trimethoprim-sulfamethoxazole (TMP-SMX)
6%
Primary Prophylaxis
6%
